View Mobile Site
  • Bookmark and Share

High court will review $6.8 million verdict against drug maker

Text Size: Small Large Medium
Posted: January 18, 2008 4:15 p.m.
Updated: February 2, 2008 5:00 a.m.
    WASHINGTON — A drug manufacturer won Supreme Court review Friday of a $6.8 million verdict in the case of a woman whose arm had to be amputated after she was injected with one of its medications.
    A jury in Vermont awarded the money to Diana Levine, who sued Wyeth after she was injected with its Phenergan nausea medication. The drug was inadvertently injected into an artery, which was seriously damaged. Doctors later amputated her arm.
    Wyeth contends it should not have been subjected to the lawsuit because the company had the approval of the U.S. Food and Drug Administration for the warning label that accompanied the drug.
    In upholding that verdict, the Vermont Supreme Court said state regulators could require sterner warnings than their federal counterparts about a drug’s potential side effects. Federal labeling requirements ‘‘create a floor, not a ceiling’’ for state regulation, the state court said.
    Wyeth has said the company recommended a label change to the FDA, but the agency told it to keep the existing language.
    The court separately is considering two other cases in which companies say federal laws pre-empt lawsuits.
    The case is Wyeth v. Levine, 06-1249.

SUBSCRIBE to the Statesboro Herald print edition or online e-Edition and get EXCLUSIVE news and information online with complete access to all complete stories on statesboroherald.com. Now you'll have Soundoff, Local Birth Announcements and columnists like Jan Moore, Larry Sheehy, Kathy Bradley, John Bressler and Holli Bragg. Also, Letters to the Editor, Local Editorials and many new exclusive items will all be there just for you! And, when you're away from home, you can read the paper page by page anywhere, anytime from your computer with your subscription.

COMMENTS

SUBMIT A COMMENT

Commenting is not available.

Hot Topics

Most Popular

Commenting not available.

Please wait ...